Oral Hypoglycemic Agents (OHAs) Market Analysis: Opportunities, Risks & Forecast Scenarios
Data Bridge Market Research analyses that the Oral hypoglycemic agents (OHAs) Market which was USD 61.20 billion in 2022, would rocket up to USD 83.75 billion by 2030, and is expected to undergo a CAGR of 4.00% during the forecast period.
